1302.4000 -6.00 (-0.46%)
NSE Sep 24, 2025 14:28 PM
Volume: 522.3K
 

1302.40
-0.46%
Chola Wealth Direct
Background: Dr. Reddy's is a global generic pharmaceutical company with focus on the US, Europe, Russia and India. Finished dosage and API account for a bulk of the revenues, with up to 60% of sales derived from overseas operations. With a strong research pipeline, its R&D; is focused in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infections. Dr. Reddy's offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars, differentiated formulations and NCEs. It has one of the largest ANDA & a patent challenge pipeline has strengthened presence through the launch of several...
Dr. Reddy's Laborato.. has an average target of 1278.56 from 9 brokers.
More from Dr. Reddy's Laboratories Ltd.
Recommended